NPC(SH:600713)2015-04-29 16:00Financial Performance - Operating revenue rose by 12.25% to CNY 5,895,675,750.53 year-on-year[7] - Net profit attributable to shareholders increased by 366.75% to CNY 48,249,208.25 compared to the same period last year[7] - Basic earnings per share increased by 260.00% to CNY 0.054 per share[7] - Operating profit surged by 313.17% to CNY 78,300,955.21 compared to the previous year[13] - Total profit increased by 214.75% to RMB 77,595,880.78 compared to RMB 24,653,235.86 in the previous period[17] - Net profit for Q1 2015 reached CNY 58,164,315.26, compared to CNY 15,263,351.81 in Q1 2014, representing a significant increase of 280.56%[40] - The net profit attributable to shareholders of the parent company was CNY 48,249,208.25, up from CNY 10,337,166.34, marking an increase of 366.73% year-over-year[40] - The company's total comprehensive income for the current period is -¥5,810,243.29, compared to -¥31,258,823.59 in the previous period, reflecting a significant improvement in overall financial performance[43] Assets and Liabilities - Total assets increased by 5.69% to CNY 12,008,623,105.17 compared to the end of the previous year[7] - Current assets totaled CNY 10,741,043,539.62, up from CNY 10,104,805,615.05 at the start of the year, indicating a growth of approximately 6.3%[31] - Total liabilities reached CNY 9,505,771,674.86, compared to CNY 8,924,967,227.26 at the beginning of the year, marking an increase of approximately 6.5%[33] - Total liabilities increased to CNY 2,398,106,631.47 from CNY 1,670,511,146.97, reflecting a rise of 43.51%[37] - Significant increase in other current liabilities by 3464.71% to CNY 822,117,227.52, attributed to the issuance of targeted financing instruments[11] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 291,999,996.71, compared to a net outflow of CNY 154,093,241.23 in the previous year[7] - The net cash flow from operating activities decreased to -RMB 291,999,996.71 from -RMB 154,093,241.23, indicating a significant decline[17] - The net cash flow from investing activities decreased to -RMB 28,409,344.01 from -RMB 15,269,079.63, reflecting reduced investment activity[17] - The net cash flow from financing activities increased to RMB 415,891,713.58 from RMB 126,180,202.00, representing a growth of 229.60%[17] - Total cash outflow from operating activities was ¥5,136,958,895.90, compared to ¥4,898,570,998.43 in the previous period, indicating increased operational costs[46] - Financing activities generated a net cash inflow of ¥415,891,713.58, an increase from ¥126,180,202.00 in the previous period, indicating improved financing conditions[47] Investments and Financing - The company issued non-public targeted debt financing tools totaling RMB 800 million with an interest rate of 5.4%[20] - The company plans to issue up to RMB 2 billion in short-term financing bonds to optimize its debt structure[20] - The company transferred 28.57% of its stake in Beijing Zhibo High-Tech Biotechnology Co., Ltd. for RMB 25,625.21 million[24] - The company received ¥800,000,000.00 from bond issuance, which is double the amount of ¥400,000,000.00 received in the previous year[48] Shareholder Information - The number of shareholders reached 54,670 by the end of the reporting period[9] - The company reported a cash dividend plan to distribute no less than 30% of the distributable profits in the first profitable accounting year[28] - The company’s strategic investor, Alliance Healthcare Asia Pacific Limited, holds a 12% stake following a merger with Walgreens Boots Alliance[15] Operational Metrics - The weighted average return on net assets increased by 1.251 percentage points to 2.228%[7] - The company's cash and cash equivalents decreased to CNY 1,588,366,815.06 from CNY 1,907,379,618.35, a decline of about 16.7%[31] - Accounts receivable increased to CNY 6,169,929,553.13 from CNY 5,037,512,762.19, reflecting a growth of approximately 22.5%[31] - Inventory rose to CNY 1,884,409,906.25 from CNY 1,717,961,062.57, representing an increase of about 9.7%[31] - Short-term borrowings slightly decreased to CNY 3,478,020,000.00 from CNY 3,540,037,000.00, a reduction of approximately 1.8%[32] Corporate Governance - The company’s board of directors was restructured, with new members elected on January 29, 2015[16] - The company committed to maintaining operational independence and avoiding competition with its subsidiaries[27]